The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits under 2 milliliters. Trump floats cancelling election, then insists he won't ...

Introduction: Adipose tissue, once viewed primarily as an energy reservoir, is now recognized as an endocrine organ involved in various physiological functions, including energy balance and immune ...

A new, implantable, ultrasound-based blood pressure monitoring system represents a promising alternative to conventional tools for continuous, unobtrusive blood pressure measurement. Accurate, ...

Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...